Effectiveness of dexmedetomidine used as an adjuvant with ropivacaine for ultrasound-guided iliohypogastric, illioinguinal and genitofemoral nerve block for inguinal hernia repair surgery

Evaluation of effectiveness of dexmedetomidine used as an adjuvant with ropivacaine 0.5 percent for ultrasound-guided iliohypogastric,ilioinguinal and genitofemoral nerve block as a sole anaesthetic technique in patients undergoing inguinal hernia repair A randomised double blinded controlled study - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088360

Enrollment

Registered

2025-06-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K409- Unilateral inguinal hernia, without obstruction or gangrene

Interventions

Intervention1: Regional Anaesthesia: Ultrasound Guided iliohypogastric, ilioinguinal and genitofemoral nerve block Control Intervention1: Dexmedetomidine, Ropivacaine: Evaluation of effectiveness of D

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with American Society of Anaesthesiologist (ASA) Physical Status (PS) 1 to 3 2. Duration of surgery less than 2 hours

Exclusion criteria

Exclusion criteria: 1. Patients who will not give consent. 2. Infection at the puncture site. 3. Patients with age lesser than 18 years and greater than 65 years 4. Patients with BMI greater than 35 kg per m2 5. Patients with history of allergy to local anaesthetic or dexmedetomidine 6. Patients with resting heart rate lesser than 50 per min. 7. Patients with history of unstable angina or myocardial infarction or complete heart block. 8. Patients with any known severe cardiac, respiratory, renal,or hepatic disease. 9. Patients with history of any psychiatric,neurological disease or seizure disorder. 10. Patients with history of bleeding disorders or deranged coagulation profile.

Design outcomes

Primary

Measure	Time frame
To compare Duration of Analgesia in both the groupsTimepoint: Duration of analgesia is the time postoperatively when patient will demand for rescue analgesia or when patients VAS score is equal to or more than 4 in first 24 hrs.	—

Secondary

Measure	Time frame
To compare Onset of sensory blockTimepoint: Immediately after block in minutes.;To compare duration of sensory blockTimepoint: Assessed postoperatively in first 24 hrs;To compare visual analog scaleTimepoint: Assessed postoperatively at 1 hr 2 hr 4 hr 6 hr 12 hr 18 hr 25 hr;To compare total rescue analgesic consumptionTimepoint: postoperatively in first 24 hours;To compare postoperatively patient satisfaction scoreTimepoint: Assessed after completion of surgery;To compare surgeon satisfaction scoreTimepoint: Assessed after completion of surgery	—

Measure

Time frame

To compare Onset of sensory blockTimepoint: Immediately after block in minutes.;To compare duration of sensory blockTimepoint: Assessed postoperatively in first 24 hrs;To compare visual analog scaleTimepoint: Assessed postoperatively at 1 hr 2 hr 4 hr 6 hr 12 hr 18 hr 25 hr;To compare total rescue analgesic consumptionTimepoint: postoperatively in first 24 hours;To compare postoperatively patient satisfaction scoreTimepoint: Assessed after completion of surgery;To compare surgeon satisfaction scoreTimepoint: Assessed after completion of surgery

—

Countries

India

Contacts

Public ContactIdris Ezzy

RNT Medical College Udaipur

idrisezzy110@gmail.com8233936212

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026